Table 1.
Baseline parameters of patients with type 1 and type 2 diabetes.
| Characteristics | DM type 1 n = 112 |
DM type 2 n = 390 |
|---|---|---|
| Diabetes duration, y | 28 ± 15 | 14 ± 10 |
| ≤10 years, n (%) | 12 (10.7%) | 166 (42.6%) |
| 11–19 years, n (%) | 24 (21.4%) | 133 (34.1%) |
| ≥20 years, n (%) | 76 (67.9%) | 91 (23.3%) |
| Gender, m/w (% of total) | 56/56 (50.0%/50.0%) | 196/194 (50.3%/49.7%) |
| Age, mean (SD), y | 52 ± 17 | 65 ± 12 |
| Age, n (%) | ||
| ≤60 years | 74 (66.1%) | 129 (33.1%) |
| 61–64 years | 5 (4.5%) | 60 (15.4%) |
| 65–69 years | 11 (9.8%) | 46 (11.8%) |
| 70–74 years | 14 (12.5%) | 58 (14.9%) |
| 75–79 years | 5 (4.5%) | 56 (14.4%) |
| ≥80 years | 3 (2.7%) | 41 (10.5%) |
| BMI, kg/m² | 25.7 ± 3.9 | 33.0 ± 8.2 |
| Hypertension, n (%) | 59 (52.7%) | 347 (89.0%) |
| Systolic blood pressure, mmHg | 135 ± 15 | 138 ± 19 |
| Diastolic blood pressure, mmHg | 81 ± 10 | 81 ± 12 |
| Nicotine use, n (%) | 8 (7.1%) | 41 (10.5%) |
| History of cerebrovascular disease, n (%) | 4 (3.6%) | 43 (11.0%) |
| History of cardiovascular disease, n (%) | 11 (9.8%) | 114 (29.2%) |
| HbA1c (%) | 7.4 ± 1.1 | 7.3 ± 1.5 |
| Triglyceride level (mg/dL) | 94 ± 55 | 213 ± 217 |
| Total cholesterol level (mg/dL) | 180 ± 35 | 181 ± 40 |
| LDL cholesterol level (mg/dL) | 91 ± 26 | 94 ± 32 |
| HDL cholesterol level (mg/dL) | 70 ± 22 | 48 ± 14 |
| Antidiabetic treatment, n (%) | ||
| Lifestyle | 0 (0%) | 34 (8.7%) |
| Oral agents | 0 (0%) | 159 (40.8%) |
| Insulin treatment | 112 (100%) | 197 (50.5%) |